Page last updated: 2024-08-22

hyaluronoglucosaminidase and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

hyaluronoglucosaminidase has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, K; Koga, A; Kohi, S; Matayoshi, N; Sato, N	1

Other Studies

1 other study(ies) available for hyaluronoglucosaminidase and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

Article	Year
KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer. Oncotarget, 2017, Mar-07, Volume: 8, Issue:10 Topics: Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Inflammation; Interleukin-1beta; Molecular Weight; Nitrobenzenes; Pancreatic Neoplasms; Phenotype; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfonamides	2017

Article

Year

KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.

Oncotarget, 2017, Mar-07, Volume: 8, Issue:10

Topics: Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Inflammation; Interleukin-1beta; Molecular Weight; Nitrobenzenes; Pancreatic Neoplasms; Phenotype; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfonamides

2017